In Vivo Lithium Treatment Effects on Gene Expression Levels in Lymphoblastoid Cell Lines From Human Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

May 5, 2012

Primary Completion Date

May 11, 2023

Study Completion Date

May 11, 2023

Conditions
Drug Mechanism
Interventions
DRUG

Lithium Carbonate

"The dose has been selected in order to achieve a therapeutic range of 0.6 - 0.8 mmol/L.~Dose titration Day 1: 1 capsule of 300 mg at bedtime Days 2 to 7: 1 capsule of 600 mg at bedtime Day 8: lithium serum levels will be tested and the dose will be adjusted proportionally to a target range of 0.6 - 0.8 mmol/L by increments of 150 mg or 300 mg."

Trial Locations (1)

B3H 2E2

Department of Psychiatry, Abbie J Lane Building, Halifax

All Listed Sponsors
lead

Nova Scotia Health Authority

OTHER

NCT01565759 - In Vivo Lithium Treatment Effects on Gene Expression Levels in Lymphoblastoid Cell Lines From Human Healthy Subjects | Biotech Hunter | Biotech Hunter